ASX
Alterity Therapeutics
ATH:ASX•Healthcare
Sensitive ASX Announcement
PBT2-Phase IIa Clinical Trial-Alzheimer's Disease Patients
Published: 11/05/06, 04:15pm (AEST)•2 pages